Zealand Pharma A/S (ZLDPF)
47.64
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Zealand Pharma Cash and Short Term Investments (Annual) : 2.376B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.376B |
| December 31, 2024 | 1.142B |
| December 31, 2023 | 241.99M |
| December 31, 2022 | 169.04M |
| December 31, 2021 | 218.36M |
| December 31, 2020 | 206.72M |
| December 31, 2019 | 207.38M |
| December 31, 2018 | 177.58M |
| December 31, 2017 | 107.06M |
| December 31, 2016 | 47.80M |
| December 31, 2015 | 64.08M |
| Date | Value |
|---|---|
| December 31, 2014 | 87.47M |
| December 31, 2013 | 57.36M |
| December 31, 2012 | 85.86M |
| December 31, 2011 | 74.70M |
| December 31, 2010 | 78.54M |
| December 31, 2009 | 27.88M |
| December 31, 2008 | 39.16M |
| December 31, 2007 | 48.29M |
| December 31, 2006 | 55.10M |
| December 31, 2005 | 31.04M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Genmab A/S | 1.715B |
| Ascendis Pharma A/S | 723.51M |
| Bavarian Nordic A/S | 524.17M |
| Evaxion AS | 23.23M |
| Novo Nordisk A/S | 4.240B |